| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CELL | Common Stock | Options Exercise | -74 K | -41.3% | 105 K | Oct 2, 2023 | Direct | F1, F2 | ||
| transaction | CELL | Common Stock | Disposed to Issuer | -105 K | -100% | 0 | Oct 2, 2023 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the "Merger Agreement"), by and among Bruker Corporation ("Bruker"), Bird Mergersub Corporation ("Merger Sub") and Phenomex Inc. (the "Company"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the "Merger"), and each restricted stock unit ("RSU") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the "Merger Consideration"). |
| F2 | Pursuant to the Merger, the Reporting Person disposed of each RSU held by her in exchange for the Merger Consideration. |
| F3 | Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share ("Common Stock") held by the Reporting Person was cancelled and converted into the right to receive the Merger Consideration. |
| F4 | Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by her in exchange for the Merger Consideration. |